Literature DB >> 15277231

The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes.

Jun-Ichi Satoh1, Takashi Yamamura, Kunimasa Arima.   

Abstract

The 14-3-3 protein family consists of acidic 30-kd proteins expressed at high levels in neurons of the central nervous system. Seven isoforms form a dimeric complex that acts as a molecular chaperone that interacts with key signaling components. Recent studies indicated that the 14-3-3 protein identified in the cerebrospinal fluid of various neurological diseases including multiple sclerosis (MS) is a marker for extensive brain destruction. However, it remains unknown whether the 14-3-3 protein plays an active role in the pathological process of MS. To investigate the differential expression of seven 14-3-3 isoforms in MS lesions, brain tissues of four progressive cases were immunolabeled with a panel of isoform-specific antibodies. Reactive astrocytes in chronic demyelinating lesions intensely expressed beta, epsilon, zeta, eta, and sigma isoforms, among which the epsilon isoform is a highly specific marker for reactive astrocytes. Furthermore, protein overlay, mass spectrometry, immunoprecipitation, and double-immunolabeling analysis showed that the 14-3-3 protein interacts with both vimentin and glial fibrillary acidic protein in cultured human astrocytes. These results suggest that the 14-3-3 protein plays an organizing role in the intermediate filament network in reactive astrocytes at the site of demyelinating lesions in MS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277231      PMCID: PMC1618573          DOI: 10.1016/s0002-9440(10)63322-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  70 in total

Review 1.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

2.  Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis.

Authors:  H Goto; H Kosako; K Tanabe; M Yanagida; M Sakurai; M Amano; K Kaibuchi; M Inagaki
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

3.  Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function.

Authors:  K Broadie; E Rushton; E M Skoulakis; R L Davis
Journal:  Neuron       Date:  1997-08       Impact factor: 17.173

4.  The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture.

Authors:  J Satoh; K Kurohara; M Yukitake; Y Kuroda
Journal:  Eur Neurol       Date:  1999       Impact factor: 1.710

5.  Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Bodemer; O Gefeller; M Otto; S Poser; J Wiltfang; O Windl; H A Kretzschmar; T Weber
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

6.  14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner.

Authors:  A Craparo; R Freund; T A Gustafson
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

7.  Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein.

Authors:  H Wakui; A P Wright; J Gustafsson; J Zilliacus
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

8.  Menin's interaction with glial fibrillary acidic protein and vimentin suggests a role for the intermediate filament network in regulating menin activity.

Authors:  Juan Lopez-Egido; Janet Cunningham; Mikael Berg; Kjell Oberg; Erik Bongcam-Rudloff; Anders Gobl
Journal:  Exp Cell Res       Date:  2002-08-15       Impact factor: 3.905

9.  14-3-3sigma is a p53-regulated inhibitor of G2/M progression.

Authors:  H Hermeking; C Lengauer; K Polyak; T C He; L Zhang; S Thiagalingam; K W Kinzler; B Vogelstein
Journal:  Mol Cell       Date:  1997-12       Impact factor: 17.970

10.  Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin.

Authors:  M Pekny; C B Johansson; C Eliasson; J Stakeberg; A Wallén; T Perlmann; U Lendahl; C Betsholtz; C H Berthold; J Frisén
Journal:  J Cell Biol       Date:  1999-05-03       Impact factor: 10.539

View more
  20 in total

1.  Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis.

Authors:  Yan Pan; Li-jun Zhong; Hong Zhou; Xin Wang; Kui Chen; Hao-peng Yang; Yilixiati Xiaokaiti; Aikebaier Maimaiti; Ling Jiang; Xue-jun Li
Journal:  Acta Pharmacol Sin       Date:  2012-06       Impact factor: 6.150

2.  Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties.

Authors:  Orly Weinreb; Tamar Amit; Silvia Mandel; Moussa B H Youdim
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

3.  Microwave and magnetic (M(2) ) proteomics of the experimental autoimmune encephalomyelitis animal model of multiple sclerosis.

Authors:  Itay Raphael; Swetha Mahesula; Karan Kalsaria; Venkat Kotagiri; Anjali B Purkar; Manjushree Anjanappa; Darshit Shah; Vidya Pericherla; Yeshwant Lal Avinash Jadhav; Rekha Raghunathan; Michael Vaynberg; David Noriega; Nazul H Grimaldo; Carola Wenk; Jonathan A L Gelfond; Thomas G Forsthuber; William E Haskins
Journal:  Electrophoresis       Date:  2012-12       Impact factor: 3.535

Review 4.  Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.

Authors:  Violaine K Harris; Saud A Sadiq
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

5.  Glial fibrillary acidic protein filaments can tolerate the incorporation of assembly-compromised GFAP-delta, but with consequences for filament organization and alphaB-crystallin association.

Authors:  Ming-Der Perng; Shu-Fang Wen; Terry Gibbon; Jinte Middeldorp; Jacqueline Sluijs; Elly M Hol; Roy A Quinlan
Journal:  Mol Biol Cell       Date:  2008-08-06       Impact factor: 4.138

6.  Proteomic analysis of human cerebral endothelial cells activated by glutamate/MK-801: significance in ischemic stroke injury.

Authors:  Alireza Minagar; J Steven Alexander; Roger E Kelley; Michael Harper; Merilyn H Jennings
Journal:  J Mol Neurosci       Date:  2008-10-09       Impact factor: 3.444

7.  Activation of NF-κB signalling by fusicoccin-induced dimerization.

Authors:  Malgorzata Skwarczynska; Manuela Molzan; Christian Ottmann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-26       Impact factor: 11.205

8.  The construction of EpCAM/vimentin-PLGA/lipid immunomagnetic microspheres and the isolation of circulating tumor cells from lung cancer.

Authors:  Guolei Li; Yun Wang; Guoliang Tan
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

9.  Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.

Authors:  Irena Dujmovic
Journal:  Mult Scler Int       Date:  2011-05-02

10.  Proteomic analysis of human cerebral endothelial cells activated by multiple sclerosis serum and IFNbeta-1b.

Authors:  J Steven Alexander; Alireza Minagar; Michael Harper; Sherry Robinson-Jackson; Merilyn Jennings; Stacy J Smith
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 2.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.